Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Iñiguez-Muñoz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Research Square|November 24, 2025
Epigenetic programs shaping lung metastasis in triple-negative breast cancerDiego Marzese, Andres Bedoya-Lopez, Javier Orozco, et al.
Cellular and Molecular Life Sciences : CMLS|June 20, 2024
Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elementsSandra Iñiguez-Muñoz, Pere Llinàs-Arias, Miquel Ensenyat-Mendez, et al.
Scientific Reports|May 27, 2026
Distinct epigenetic alterations and accelerated mitotic aging define second primary breast cancersAndrés F Bedoya-López, Javier I J Orozco, Pere Llinàs-Arias, et al.
NPJ Precision Oncology|August 15, 2025
Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancerAndrés F Bedoya-López, Sookyung Ahn, Miquel Ensenyat-Mendez, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Research Square|November 24, 2025
Epigenetic programs shaping lung metastasis in triple-negative breast cancerDiego Marzese, Andres Bedoya-Lopez, Javier Orozco, et al.
Cellular and Molecular Life Sciences : CMLS|June 20, 2024
Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elementsSandra Iñiguez-Muñoz, Pere Llinàs-Arias, Miquel Ensenyat-Mendez, et al.
Scientific Reports|May 27, 2026
Distinct epigenetic alterations and accelerated mitotic aging define second primary breast cancersAndrés F Bedoya-López, Javier I J Orozco, Pere Llinàs-Arias, et al.
NPJ Precision Oncology|August 15, 2025
Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancerAndrés F Bedoya-López, Sookyung Ahn, Miquel Ensenyat-Mendez, et al.
Pageof 1